Regulation of duodenal bicarbonate secretion during stress by corticotropin-releasing factor and beta-endorphin.

Por Lenz, H J
Publicado em 1989

Cerebroventricular calcitonin gene-related peptide inhibits rat duodenal bicarbonate secretion by release of norepinephrine and vasopressin.

Por Lenz, H J, Brown, M R
Publicado em 1990

Corticotropin-releasing factor. Mechanisms to inhibit gastric acid secretion in conscious dogs.

Por Lenz, H J, Hester, S E, Brown, M R
Publicado em 1985

Noradrenergic inhibition of canine gallbladder contraction and murine pancreatic secretion during stress by corticotropin-releasing factor.

Por Lenz, H J, Messmer, B, Zimmerman, F G
Publicado em 1992

Calcitonin gene related peptide inhibits basal, pentagastrin, histamine, and bethanecol stimulated gastric acid secretion.

Por Lenz, H J, Mortrud, M T, Rivier, J E, Brown, M R
Publicado em 1985

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

Por Stoehlmacher, J, Park, D J, Zhang, W, Yang, D, Groshen, S, Zahedy, S, Lenz, H-J
Publicado em 2004

Phenotype and functional properties of Vicia villosa agglutinin (VVA) binding T cells in patients with Crohn's disease: detection of contrasuppressor activity in patients lacking e...

Por Raedler, A, Lenz, H J, Sandgren, K, de Weerth, A, Enversen, S, Schreiber, S, Thiele, H G, Greten, H
Publicado em 1988

Increased sensitivity of gastric acid secretion to gastrin in cirrhotic patients with portacaval shunt.

Por Lenz, H J, Struck, T, Greten, H, Koss, M A, Eysselein, V E, Walsh, J H, Isenberg, J I
Publicado em 1987

Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

Por Iqbal, S., Goldman, B., Fenoglio-Preiser, C. M., Lenz, H. J., Zhang, W., Danenberg, K. D., Shibata, S. I., Blanke, C. D.
Publicado em 2011

A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer

Por El-Khoueiry, A. B., Ramanathan, R. K., Yang, D. Y., Zhang, W., Shibata, S., Wright, J. J., Gandara, D., Lenz, H. J.
Publicado em 2011

Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)

Por Louie, S G, Ely, B, Lenz, H-J, Albain, K S, Gotay, C, Coleman, D, Raghavan, D, Shields, A F, Gold, P J, Blanke, C D
Publicado em 2013

Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s).

Por Danenberg, P V, Horikoshi, T, Volkenandt, M, Danenberg, K, Lenz, H J, Shea, L C, Dicker, A P, Simoneau, A, Jones, P A, Bertino, J R
Publicado em 1992

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

Por El-Khoueiry, A B, Rankin, C, Siegel, A B, Iqbal, S, Gong, I-Y, Micetich, K C, Kayaleh, O R, Lenz, H-J, Blanke, C D
Publicado em 2014

Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer

Por Lurje, G., Zhang, W., Schultheis, A. M., Yang, D., Groshen, S., Hendifar, A. E., Husain, H., Gordon, M. A., Nagashima, F., Chang, H. M., Lenz, H.-J.
Publicado em 2008

GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients

Por Winder, T., Bohanes, P., Zhang, W., Yang, D., Power, D. G., Ning, Y., Gerger, A., Wilson, P. M., Tang, L. H., Shah, M., Lee, A. S., Lenz, H.-J.
Publicado em 2011

LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy

Por Szkandera, J, Herzog, S, Pichler, M, Stiegelbauer, V, Stotz, M, Schaberl-Moser, R, Samonigg, H, Asslaber, M, Lax, S, Leitner, G, Renner, W, Lenz, H-J, Berghold, A, Gerger, A
Publicado no Pharmacogenomics J (2015)

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six ran...

Por Arnold, D., Lueza, B., Douillard, J.-Y., Peeters, M., Lenz, H.-J., Venook, A., Heinemann, V., Van Cutsem, E., Pignon, J.-P., Tabernero, J., Cervantes, A., Ciardiello, F.
Publicado no Ann Oncol (2017)

Variations in genes involved in dormancy associated with outcome in patients with resected colorectal liver metastases

Por Stremitzer, S., Zhang, W., Yang, D., Ning, Y., Stintzing, S., Sunakawa, Y., Sebio, A., Yamauchi, S., Matsusaka, S., Parekh, A., Barzi, A., El-Khoueiry, R., Stift, J., Wrba, F., Gruenberger, T., Lenz, H.-J.
Publicado no Ann Oncol (2015)

A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials

Por Sebio, A., Stintzing, S., Heinemann, V., Sunakawa, Y., Zhang, W., Ichikawa, W., Tsuji, A., Takahashi, T., Parek, A., Yang, D., Cao, S., Ning, Y., Stremitzer, S., Matsusaka, S., Okazaki, S., Barzi, A., Berger, M., Lenz, H-J
Publicado no Pharmacogenomics J (2016)

Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and...

Por Berger, M D, Stintzing, S, Heinemann, V, Yang, D, Cao, S, Sunakawa, Y, Ning, Y, Matsusaka, S, Okazaki, S, Miyamoto, Y, Suenaga, M, Schirripa, M, Soni, S, Zhang, W, Falcone, A, Loupakis, F, Lenz, H -J
Publicado no Ann Oncol (2017)